Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1.

"Declaration of interest statement P.-Y.S. and X.X. have filed a patent on the SARS-CoV-2 reverse genetic system. Other authors declare no competing interests. Disclosure statement No potential conflict of interest was reported by the author(s)."

"We thank many originating laboratories, who share and deposit their sequencing results timely in the GISAID database. P.-Y.S. and X.X. were supported by NIH contract HHSN272201600013C, and awards from the Sealy & Smith Foundation, the Kleberg Foundation, the John S. Dunn Foundation, the Amon G. Carter Foundation, the Summerfield Robert Foundation, and Edith and Robert Zinn. We thank the participants from whom the serum specimens were obtained. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript."